Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-16
1997-12-09
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424405, 424430, 424435, 424443, 424484, 530327, 530326, 530325, 530324, A61K 3100
Patent
active
056960786
ABSTRACT:
Peptides representing defined portions of the amino acid sequences of naturally occurring human and macaque histatins, modified peptides, expression vectors encoding these peptides, and compositions and methods for treatment of fungal infection are described. Some of the histatin-based peptides exhibit superior anti-fungal activity to native, intact histatins. Isolated, naturally occurring macaque histatins and peptide analogs are also described.
REFERENCES:
patent: 4705777 (1987-11-01), Lehrer et al.
patent: 4725576 (1988-02-01), Pollock et al.
patent: 5032574 (1991-07-01), Wilde et al.
patent: 5126257 (1992-06-01), Gabay et al.
patent: 5221732 (1993-06-01), Chen et al.
patent: 5225399 (1993-07-01), Zasloff et al.
patent: 5239059 (1993-08-01), Zasloff et al.
patent: 5304633 (1994-04-01), Tomita et al.
patent: 5324716 (1994-06-01), Selsted et al.
Oppenheim, F.G. et al., "Isolation and Characterization of a Major Histatin from Macaque Parotid Secretion," FASEB J. 4(7): A2165 (Apr. 1990).
Xu, T. and Oppenheim, F.G., "Structure/Function Analysis of Anti-Candida Activities of Histatin 1," J. Dent. Res. 68: 973 (Jun. 1989).
Oppenheim, F.G. et al., "Histatins, A Novel Family of Histidine-Rich Proteins in Human Parotid Secretion," J. Biol. Chem. 263(16): 742-777 (Jun. 5, 1988).
Troxler, R.F. et al., "Structural Relationship between Human Salivary Histatins," J. Dent. Res. 69(1): 2-6 (Jan. 1990).
Santarpia III, R.P. et al., "Preliminary Findings for in vivo Efficacy of Salivary Histadine-Rich Polypeptides," J. Dent. Res. 69: 173 (Mar. 1990).
Iwaki, M. et al., "Oral Immunization with Recombinant Streptococcus lactis Carrying the Streptococcus mutans Surface Protein Antigen Gene," Infect. Immun. 58(9): 2929-2934 (Sep. 1990).
Macrina, F.L. et al., "Chimeric Streptococcal Plasmids and Their Use as Molecular Cloning Vehicles in Streptococcus sanguis (Challis)," J. Bacteriol. 143(3): 1425-1435 (Sep. 1980).
Kuramitsu, H.K. and Long, C.M., "Plasmid-Mediated Transformation of Streptococcus mutans," Infect. Immun. 36(1): 435-436 (Apr. 1982).
Svanberg, M. et al., "Oral Implantation in Humans of Streptococcus mutans Strains with Different Degrees of Hydrophobicity," Infect. Immun. 43(3): 817-821 (Mar. 1984).
Docherty, J.J. and Pollock, J.J., "Inactivation of Herpes Simplex Virus Types 1 and 2 by Synthetic Histidine Peptides," Antimicrobial Agents and Chemotherapy 31(10): 1562-1566 (Oct. 1987).
Nishikata, M. et al., "Salivary Histatin as an Inhibitor of a Protease Produced by the Oral Bacterium Bacteroides gingivalis," Biochem. Biophys. Res. Comm. 174(2): 625-630 (Jan. 31, 1991).
Xu, T. et al., "Primary Structure and Anti-Candidal Activity of the Major Histatin from Parotid Secretion of the Subhuman Primate Macaca fascicularis," J. Dent. Res. 69: 1717-1723 (Nov. 1990).
Xu, T. and Oppenheim, F.G., "Anti-Fungal Functional Domain of Histatin 3," J. Dent. Res. 70: 497 (Apr. 1991).
Xu, T. et al., "Anticandidal Activity of Major Human Salivery Histatins," Infect. Immun. 59(8): 2549-2554 (Aug. 1991).
Raj, P.A. et al., "Salivary Histatin 5: Dependence of Sequence, Chain Length, and Helical Conformation for Candidacidal Activity," J. of Biol. Chem. 265(7): 3898-3905 (Mar. 5, 1990).
Murakami, Y. et al., "Inhibitory Effects of Synthetic Histidine-Rich Peptides on Haemagglutination by Bacteroides gingivalis 381," Archives of Oral Biol. 35(9): 775-777 (1990).
Minaguchi, K. and A. Bennick, "Genetics of Human Salivary Proteins," J. Dent. Res. 68(1): 2-15 (Jan., 1989).
Santarpia III, R.P. et al., "A Comparison of the Inhibition of Blastospore Viability and Germ-Tube Development in Candida albicans by Histidine Peptides and Ketoconazole," Archives of Oral Biol. 33(8): 567-573 (1988).
vanderSpek, J.C. et al., "Localization of the Genes for Histatins to Human Chromosome 4q13 and Tissue Distribution of the mRNAs," Am. J. Hum. Genet. 45: 381-387 (1989).
Sabatini, L.M. et al., "Tissue Distribution of RNAs for Cystatins, Histatins, Statherin, and Proline-rich Salivary Proteins in Humans and Macaques," J. of Dental Res. 68(7): 1138-1145 (Jul., 1989).
vanderSpek, J.C. et al., "Molecular Cloning of Human Submandibular Histatines," Archives of Oral Biol., 35(2): 137-143 (1990).
Sabatini, L.M. et al., "Tissue Distribution of RNAs for Salivary-Type Proteins in Humans and Monkeys: Proline-rich Proteins, Statherin, Cystatins, and Histidine-rich Proteins," Am. J. of Human Genetics 43(3rd Supplement) A199 (Abstract) (1988).
Sugiyama, K. et al., "Rapid Purification and Characterization of Histatins (Histidine-Rich Polypeptides) from Human Whole Saliva," Archives of Oral Biol. 35(6)415-419 (1990).
Dickinson, D.P. et al., "Human Submandibular Gland Statherin and Basic Histidine-rich Peptide are Encoded by Highly Abundant mRNA's Derived from a Common Ancestral Sequence," Biochem. and Biophys. Res. Comm. (149(2): 784-790 (Dec. 16, 1987).
Sabatini, L.M. et al., "Histatins, A Family of Salivary Histidine-Rich Proteins, are Encoded by at Lease Two Loci (His 1 and His 2)," Biophys. Res. Communications 160(2): 495-502 (1989).
Oppenheim Frank G.
Xu Tao
Moore William W.
The Trustees of Boston University
Wax Robert A.
LandOfFree
Methods of treating fungal infections using histatin-based pepti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating fungal infections using histatin-based pepti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating fungal infections using histatin-based pepti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607656